Keywords: Free market, the expired-patent patent, drug, drugs, patents, generic drugs, active substance, biovalilability, biological drugs, bolar clause, generic name, original or innovative drug, patent patent clustering, generic version, generic name, orphan drug, patented drug, pharmaceutical form, prescription drug, laboraties, Commission por Protection against Sanitary Risks, Ministry of Health, Mexical Social Security Institute.